Publikace
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?2017 | 1. lékařská fakulta
- Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis2017 | 1. lékařská fakulta
- Serum lipid profile changes predict neurodegeneration in interferon-beta 1a-treated multiple sclerosis patients2017 | 1. lékařská fakulta
- Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis2015 | 1. lékařská fakulta
- Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study2013 | 1. lékařská fakulta
- Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis2013 | 1. lékařská fakulta
- Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event2013 | 1. lékařská fakulta
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | 1. lékařská fakulta
- Současné a budoucí terapeutické možnosti léčby generalizované formy myasthenia gravis2023 | 1. lékařská fakulta
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | 1. lékařská fakulta
Loading network view...